The KDM6A-mutated MM cells are more sensitive to EZH2 inhibitor-induced apoptosis through reactivation of BCL6 and subsequently repression of IRF4 and c-MYC [140]. The gene discussed is KDM6A; the disease is Miyoshi myopathy.